Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains.
Enigk. Katharina K; Jentsch. Holger H; Rodloff. Arne C AC; Eschrich. Klaus K; Stingu. Catalina-Suzana CS
Key Findings
- Nisin completely inhibited growth of several oral bacteria, including potential pathogens like Streptococcus anginosus and Staphylococcus aureus.
- Melittin reduced growth of Megasphaera sp., Parvimonas micra, and Bifidobacterium longum; lactoferrin reduced Megasphaera sp., P. micra, and Selenomonas flueggei.
- Parasin‑1 and LL‑37 showed no antimicrobial activity against any of the 35 oral strains or Candida albicans.
Practical Outcomes
- For biohackers focused on oral health, nisin looks promising as a potential mouth‑wash or supplement ingredient, while LL‑37 is unlikely to help with oral infections. Melittin and lactoferrin may offer modest benefits but are not broadly effective. This study mainly confirms existing ideas about these peptides rather than providing new protocols.
Summary
The study tested five antimicrobial peptides on a range of oral bacteria and a fungus. Nisin was the strongest, stopping many common mouth microbes, while melittin and lactoferrin had limited effects. LL‑37, the peptide you asked about, showed no activity against any of the tested strains.
Abstract
<b>Background</b>: Due to the increasing emergence of multi-resistant bacteria the search for alternative antimicrobial substances is of high interest. Promising agents are antimicrobial peptides which are host defense molecules of the innate immune system in a wide range of different species. <b>Objectives</b>: The aim of this study was to assess the activity of nisin, melittin, lactoferrin, parasin-1 and LL-37 against 35 oral bacteria and <i>Candida albicans</i> employing the gold standard method for anaerobic susceptibility testing. <b>Methods</b>: The activity of the peptides was determined by an agar dilution method under anaerobic and aerobic conditions. The test media contained final peptide concentrations between 0.125 µg/ml and 8 µg/ml (melittin, lactoferrin, parasin-1, LL-37) and between 0.125 µg/ml and 128 µg/ml (nisin). <b>Results</b>: Nisin completely inhibited the growth of <i>Megasphaera</i> sp., <i>Bifidobacterium longum, Parvimonas micra, Actinomyces israelii, Actinomyces naeslundii, Actinomyces odontolyticus, Prevotella intermedia, Streptococcus anginosus, Streptococcus constellatus</i> and <i>Staphylococcus aureus</i>. Melittin and lactoferrin reduced the growth of <i>Megasphaera</i> sp., <i>P. micra, B. longum</i> (melittin) and <i>Selenomonas flueggei</i> (lactoferrin). Parasin-1 and LL-37 showed no activity. <b>Conclusion</b>: AMPs, especially nisin and to a smaller degree lactoferrin, might be promising alternatives to antibiotics because of their antimicrobial activity, high resistance to environmental conditions and partially low costs.
Study Information
pubmed
2020
2020-10-07T00:00:00.000Z
10.1080/20002297.2020.1829405
17
76